Home › Inflammatory Bowel Disease › New York › New York City
Inflammatory Bowel Disease clinical trials in New York City, NY
18 studies for Inflammatory Bowel Disease are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Pioneer Clinical Research NY, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 037, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
RecruitingPhase 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
RecruitingPhase 3
- Weill Cornell Medicine, New York
BOOM-IBD2 Pivotal Clinical Trial
Recruiting
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
RecruitingObservational studyHealthy volunteers welcome
- Icahn School of Medicine at Mount Sinai, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
RecruitingObservational study
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
RecruitingPhase 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
RecruitingPhase 4
- Columbia University Medical Center, New York
Impact of Morning Light Therapy in IBD
Recruiting
- Mount Sinai Hospital, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, New York
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Recruiting
- NYU Langone Health, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
RecruitingObservational studyHealthy volunteers welcome
- Icahn School of Medicine at Mount Sinai, New York
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RecruitingObservational study
- New York University, New York
Inflammatory Bowel Disease trials in other cities
- Boston, MA15 studies
- Miami, FL9 studies
- Seattle, WA9 studies
- Durham, NC8 studies
- Atlanta, GA8 studies
- Orlando, FL8 studies
- Houston, TX8 studies
- Washington, DC7 studies
- St. Louis, MO7 studies
- Philadelphia, PA7 studies
- Cincinnati, OH7 studies
- Baltimore, MD6 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.